Close Menu
  • Home
  • About
  • News
  • Awards
  • Media & Press
  • Video Podcasts
  • Magazines
  • Events
  • Contact
Facebook X (Twitter) Instagram
Gazet International – Global Magazine
AWARD NOMINATION
  • Home
  • About
  • News
  • Awards
  • Media & Press
  • Video Podcasts
  • Magazines
  • Events
  • Contact
You are at:Home » Dansy Labs Announces USD 120 Million Major Strategic Asset Buyout and Patents in Hong Kong and Sweden​
Press Release

Dansy Labs Announces USD 120 Million Major Strategic Asset Buyout and Patents in Hong Kong and Sweden​

Gazet InternationalBy Gazet InternationalFebruary 24, 20255 Mins Read
Facebook Twitter LinkedIn
Share
Facebook Twitter LinkedIn

In a landmark move aimed at significantly enhancing its research and development capabilities, Dansy Labs Private Limited has announced the strategic acquisition of key assets & Patents in Hong Kong and Sweden. This buyout is expected to bring about substantial progress in the companys global expansion and innovative areas of research, marking a pivotal moment in the companys growth trajectory. The long-term strategic Investment of USD 120 Million Asset Buyout & Patents in Hong Kong and Sweden encompasses a comprehensive portfolio of pioneering technologies and intellectual properties. These assets are poised to significantly augment Dansy Labs research and development capabilities, thereby expediting the advancement of next-generation products and solutions, the company’s release stated.

https://www.newsvoir.com/images/article/image1/31194_Primary_Image.jpg

Dancy Labs Private Limited

Announcing the investment of USD 120 Million Dr Ashok Tiwari Managing Director of the unlisted pharma company Dansy Labs Pvt Limited said, “ We are thrilled to share that the Board of Directors and Management have endorsed this pivotal proposal in our recent Special General Meeting. This strategic investment will open up significant opportunities in key markets across Sweden. With the capital raised from investors and NBFCs, we are poised to seize this deal and realize its full potential. The asset buyout & Patents is a critical component of Dansy Labs broader strategy to expand its global footprint. The acquired assets include state-of-the-art research facilities and cutting-edge technologies that will be integrated into Dansy Labs existing operations. This expansion is set to accelerate the development of novel pharmaceutical solutions and solidify the companys position as a leader in the industry. With the acquisition, Dansy Labs aims to bolster its innovative capabilities and enhance its competitive edge. The new assets will provide the company with advanced manufacturing capabilities and resources to drive pioneering research in various therapeutic areas. This strategic move is expected to lead to a surge in patent filings and the development of breakthrough treatments that address unmet medical needs.”

Mr Chandrakant Patil Executive Director of Dansy Labs Pvt Limited said, “This strategic asset buyout is a transformative step for Dansy Labs. It reflects our unwavering commitment to advancing research and innovation in the pharmaceutical industry. By integrating these world-class assets, we are poised to accelerate the development of cutting-edge therapies and expand our global reach. Dansy Labs has long been recognized for its commitment to quality and excellence in the pharmaceutical industry. The companys robust portfolio of active pharmaceutical ingredients (APIs) and intermediates has garnered acclaim for its superior quality and efficacy. The latest acquisition underscores Dansy Labs dedication to maintaining high standards and delivering innovative solutions that improve patient outcomes. The asset buyout is expected to have a profound impact on Dansy Labs research and development efforts. The company is set to leverage the newly acquired assets to explore novel therapeutic avenues and develop treatments that address critical health challenges. As Dansy Labs continues to push the boundaries of innovation, it remains dedicated to improving the quality of life for patients worldwide. The investment aligns with Dansy Labs mission to enhance its global footprint and strengthen its position in the pharmaceutical and healthcare sectors. By integrating these new assets, the company aims to accelerate its development of cutting-edge solutions and maintain its competitive edge in the industry.”

Dansy Labs Private Limited, headquartered in Mumbai, India, is a leading player in the pharmaceutical industry. The company specializes in the import and export of active pharmaceutical ingredients (APIs) and intermediates. With a strong focus on research and innovation, Dansy Labs is committed to delivering high-quality solutions that meet the evolving needs of the global healthcare market.

About Dansy Labs
Dansy Labs is a leading global pharmaceutical company dedicated to transforming industries through innovation and excellence. With a diverse portfolio of cutting-edge products and solutions in Pharmaceutical API’s, Dansy Labs is committed to driving progress and shaping the future of technology. Dansy Labs has a significant presence in pharmaceutical Active Pharmaceutical Ingredient (API) research, particularly focused on developing innovative and sustainable methods for producing high- quality APIs, often leveraging its expertise in biotechnology, chemistry, and advanced manufacturing technologies; key areas of focus include developing new APIs for complex diseases. Dansy Labs Pvt Ltd, based in Mumbai-the commercial capital of India-stands as a beacon of pharmaceutical research and innovation. Founded with the mission to transform the pharmaceutical landscape, Dansy Labs has carved a significant niche for itself in the realm of Active Pharmaceutical Ingredient (API) research.

As one of the pioneering API manufacturing and marketing facilities in the world, Dansy Labs Pvt Ltd continues to push the boundaries of what’s possible in pharmaceutical research. The company’s vision is to harness the power of technology and innovation to improve lives and create a sustainable future. By focusing on cutting-edge research and customer-centric development, Dansy Labs is poised to remain at the forefront of pharmaceutical advancements for years to come.

Dansy labs Private limited
OFFICE NO 53-54, Kalpataru Complex,CG Rd, Chembur, Mumbai, Maharashtra 400074
www.dansylab.com.
EMAIL: info@dansylab.com

​ 

Share. Facebook Twitter LinkedIn
Previous ArticleTrump boosts Russian economy after three years of war
Next Article Centrum Broking Launches GalaxC – A Unified Investment and Trading Platform​

Related Posts

Admissions Surge as Shrewsbury International School India Prepares for its Grand Opening in Bhopal on August 8​

May 10, 2025

Mother’s Day Gifting Options by Kicky and Perky​

May 10, 2025

Sanfort Set to Launch India’s First IB Preschool Chain with a Vision for Futuristic Childhood Education​

May 10, 2025
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
Don't Miss

Admissions Surge as Shrewsbury International School India Prepares for its Grand Opening in Bhopal on August 8​

Mother’s Day Gifting Options by Kicky and Perky​

Sanfort Set to Launch India’s First IB Preschool Chain with a Vision for Futuristic Childhood Education​

Emirates Shipping Congress and IEC Telecom Drive Maritime Digital Transformation at UAE Maritime Week

Recent Posts
  • Admissions Surge as Shrewsbury International School India Prepares for its Grand Opening in Bhopal on August 8​
  • Mother’s Day Gifting Options by Kicky and Perky​
  • Sanfort Set to Launch India’s First IB Preschool Chain with a Vision for Futuristic Childhood Education​
  • Emirates Shipping Congress and IEC Telecom Drive Maritime Digital Transformation at UAE Maritime Week
  • Samsung Galaxy S25 Edge Features New Corning Gorilla Glass Ceramic 2 for Enhanced Durability​
Recent Comments
    Archives
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • October 2023
    • September 2023
    • January 2021
    Categories
    • Banking
    • Blog
    • Business
    • Corporate
    • Editor's Column
    • Events
    • Executive Spotlight
    • Finance and Investing
    • Lifestyle
    • magazine
    • podcast
    • Press Release
    • Technology
    • World
    Meta
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    About

    GAZET INTERNATIONAL


    Gazet International Magazine is a global entity that works towards providing latest information and news updates of the world. It entraps latest stories in banking, finance, lifestyle and various beats of the world. We engage in recognizing and rewarding the global organizations for their achievements in various fields and deliver justice to the nominees with valued identification and recognition of companies that indulge in the Gazet Award Ceremony.

    Facebook X (Twitter) Instagram YouTube LinkedIn
    Categories
    • Banking
    • Blog
    • Business
    • Corporate
    • Editor's Column
    • Events
    • Executive Spotlight
    • Finance and Investing
    • Lifestyle
    • magazine
    • podcast
    • Press Release
    • Technology
    • World
    Latest posts
    Finance and Investing

    TSX closes lower as investors prepare for bank earnings

    February 27, 2024
    Business

    Boehringer to release an obesity, fatty liver drug by 2027 or 2028

    February 27, 2024
    World

    New Zealand set to scrap the world’s first tobacco smoking ban

    February 27, 2024
    Blog

    A Comprehensive Guide to Understanding CFDs

    February 26, 2024
    Previous 1 … 661 662 663 664 665 … 715 Next
    Official Partner

    7ITS NEWS

    Copyright © 2025. Gazet International

    Type above and press Enter to search. Press Esc to cancel.